Literature DB >> 20631137

Genetic determinants of mouse hepatitis virus strain 1 pneumovirulence.

Julian L Leibowitz1, Rajiv Srinivasa, Shawn T Williamson, Ming Ming Chua, Mingfeng Liu, Samantha Wu, Hyojeung Kang, Xue-Zhong Ma, Jianhua Zhang, Itay Shalev, Robert Smith, Melville J Phillips, Gary A Levy, Susan R Weiss.   

Abstract

We report here investigation into the genetic basis of mouse hepatitis virus strain 1 (MHV-1) pneumovirulence. Sequencing of the 3' one-third of the MHV-1 genome demonstrated that the genetic organization of MHV-1 was similar to that of other strains of MHV. The hemagglutinin esterase (HE) protein was truncated, and reverse transcription-PCR (RT-PCR) studies confirmed previous work that suggested that the MHV-1 HE is a pseudogene. Targeted recombination was used to select chimeric viruses containing either the MHV-1 S gene or genes encoding all of the MHV-1 structural proteins, on an MHV-A59 background. Challenge studies in mice demonstrated that expression of the MHV-1 S gene within the MHV-A59 background (rA59/S(MHV-1)) increased the pneumovirulence of MHV-A59, and mice infected with this recombinant virus developed pulmonary lesions that were similar to those observed with MHV-1, although rA59/S(MHV-1) was significantly less virulent. Chimeras containing all of the MHV-1 structural genes on an MHV-A59 background were able to reproduce the severe acute respiratory syndrome (SARS)-like pathology observed with MHV-1 and reproducibly increased pneumovirulence relative to rA59/S(MHV-1), but were still much less virulent than MHV-1. These data suggest that important determinants of pneumopathogenicity are contained within the 3' one-third of the MHV-1 genome, but additional important virulence factors must be encoded in the genome upstream of the S gene. The severity of the pulmonary lesions observed correlates better with elevated levels of inflammatory cytokines than with viral replication in the lungs, suggesting that pulmonary disease has an important immunological component.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20631137      PMCID: PMC2937641          DOI: 10.1128/JVI.00330-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence.

Authors:  Lubna Kazi; Arjen Lissenberg; Richard Watson; Raoul J de Groot; Susan R Weiss
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier.

Authors:  L Kuo; G J Godeke; M J Raamsman; P S Masters; P J Rottier
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS.

Authors:  E Ontiveros; L Kuo; P S Masters; S Perlman
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

4.  Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms.

Authors:  Biao Kan; Ming Wang; Huaiqi Jing; Huifang Xu; Xiugao Jiang; Meiying Yan; Weili Liang; Han Zheng; Kanglin Wan; Qiyong Liu; Buyun Cui; Yanmei Xu; Enmin Zhang; Hongxia Wang; Jingrong Ye; Guichang Li; Machao Li; Zhigang Cui; Xiaobao Qi; Kai Chen; Lin Du; Kai Gao; Yu-Teng Zhao; Xiao-Zhong Zou; Yue-Ju Feng; Yu-Fan Gao; Rong Hai; Dongzhen Yu; Yi Guan; Jianguo Xu
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Bats are natural reservoirs of SARS-like coronaviruses.

Authors:  Wendong Li; Zhengli Shi; Meng Yu; Wuze Ren; Craig Smith; Jonathan H Epstein; Hanzhong Wang; Gary Crameri; Zhihong Hu; Huajun Zhang; Jianhong Zhang; Jennifer McEachern; Hume Field; Peter Daszak; Bryan T Eaton; Shuyi Zhang; Lin-Fa Wang
Journal:  Science       Date:  2005-09-29       Impact factor: 47.728

6.  Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus.

Authors:  J Das Sarma; L Fu; J C Tsai; S R Weiss; E Lavi
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  The murine coronavirus nucleocapsid gene is a determinant of virulence.

Authors:  Timothy J Cowley; Simon Y Long; Susan R Weiss
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

8.  Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis.

Authors:  S Navas; S H Seo; M M Chua; J Das Sarma; E Lavi; S T Hingley; S R Weiss
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

9.  Multiple regions of the murine coronavirus spike glycoprotein influence neurovirulence.

Authors:  J J Phillips; M Chua; S H Seo; S R Weiss
Journal:  J Neurovirol       Date:  2001-10       Impact factor: 2.643

10.  Murine coronavirus spike glycoprotein mediates degree of viral spread, inflammation, and virus-induced immunopathology in the central nervous system.

Authors:  Joanna J Phillips; Ming Ming Chua; Glenn F Rall; Susan R Weiss
Journal:  Virology       Date:  2002-09-15       Impact factor: 3.616

View more
  10 in total

Review 1.  Coronavirus pathogenesis.

Authors:  Susan R Weiss; Julian L Leibowitz
Journal:  Adv Virus Res       Date:  2011       Impact factor: 9.937

2.  Mechanism of Multi-Organ Injury in Experimental COVID-19 and Its Inhibition by a Small Molecule Peptide.

Authors:  Michael J Paidas; Natarajan Sampath; Emma A Schindler; Daniela S Cosio; Chima Obianuju Ndubizu; Nagarajarao Shamaladevi; Jaclyn Kwal; Suset Rodriguez; Anis Ahmad; Norma Sue Kenyon; Arumugam R Jayakumar
Journal:  Front Pharmacol       Date:  2022-05-30       Impact factor: 5.988

3.  Protective effects of long pentraxin PTX3 on lung injury in a severe acute respiratory syndrome model in mice.

Authors:  Bing Han; Xuezhong Ma; Jianhua Zhang; Yu Zhang; Xiaohui Bai; David M Hwang; Shaf Keshavjee; Gary A Levy; Ian McGilvray; Mingyao Liu
Journal:  Lab Invest       Date:  2012-06-25       Impact factor: 5.662

Review 4.  A review of genetic methods and models for analysis of coronavirus-induced severe pneumonitis.

Authors:  Brenna McGruder; Julian L Leibowitz
Journal:  J Gen Virol       Date:  2014-09-24       Impact factor: 3.891

5.  Coronavirus MHV-A59 infects the lung and causes severe pneumonia in C57BL/6 mice.

Authors:  Zhangsheng Yang; Jun Du; Gang Chen; Jie Zhao; Xuanming Yang; Lishan Su; Genhong Cheng; Hong Tang
Journal:  Virol Sin       Date:  2014-12-22       Impact factor: 4.327

Review 6.  Pathology of Coronavirus Infections: A Review of Lesions in Animals in the One-Health Perspective.

Authors:  Valentina Zappulli; Silvia Ferro; Federico Bonsembiante; Ginevra Brocca; Alessandro Calore; Laura Cavicchioli; Cinzia Centelleghe; Giorgia Corazzola; Steffen De Vreese; Maria Elena Gelain; Sandro Mazzariol; Valentina Moccia; Nicolò Rensi; Alessandro Sammarco; Filippo Torrigiani; Ranieri Verin; Massimo Castagnaro
Journal:  Animals (Basel)       Date:  2020-12-11       Impact factor: 2.752

Review 7.  T cell responses to SARS-CoV-2 in humans and animals.

Authors:  Sameer-Ul-Salam Mattoo; Jinjong Myoung
Journal:  J Microbiol       Date:  2022-02-14       Impact factor: 2.902

8.  Differentiated phenotypes of primary murine alveolar epithelial cells and their susceptibility to infection by respiratory viruses.

Authors:  Lemme P Kebaabetswe; Anoria K Haick; Tanya A Miura
Journal:  Virus Res       Date:  2013-04-29       Impact factor: 3.303

9.  Lung epithelial cells have virus-specific and shared gene expression responses to infection by diverse respiratory viruses.

Authors:  James T VanLeuven; Benjamin J Ridenhour; Andres J Gonzalez; Craig R Miller; Tanya A Miura
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

Review 10.  Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2.

Authors:  Robert W Körner; Mohamed Majjouti; Miguel A Alejandre Alcazar; Esther Mahabir
Journal:  Viruses       Date:  2020-08-12       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.